Company: NDRA
Filing Date: 2025-10-30
Form Type: 8-K
Source: 0001213900-25-103707
Chunk: 1

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 8-K
Item: Item 1.01
Chunk 1
---
 Agreement is filed as Exhibit
1.1 to this Current Report on Form 8-K, and the description of the terms of the ATM Agreement is qualified in its entirety by reference
to such exhibit. A copy of the opinion of K& L Gates LLP relating to the legality of the issuance and sale of the Shares is attached
as Exhibit 5.1 hereto.

This Current Report on Form 8-K shall not constitute
an offer to sell or the solicitation of an offer to buy the Shares, nor shall there be any offer, solicitation, or sale of the Shares
in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws
of any such state.

Item 9.01Financial Statements and Exhibits.